Exploiting the mechanisms by which various dietary macronutrients activate GPCRs on L-cells, and hence, the release of endogenous GLP-1 and PYY represents a possible therapeutic target
Victoza (liraglutide), Byetta (exenatide), Bydureon (extended-release exenatide), and Trulicity (dulaglutide) are no longer eligible for weight loss coverage under many Anthem plans
Experience the benefits of balanced hormones through our personalized Bioidentical Hormone Replacement Therapy
Cheng said there are several things that predispose patients to getting kidney stones, including obesity, Unfortunately, the obesity epidemic has only increased the risk of patients having renal stones, she continued
Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus
This holistic approach helps you feel fuller for longer, making it easier to consume fewer calories and maintain a steady, gradual weight loss